MedTrace Logo

Exercise Effects in Multiple Sclerosis

NCT05496881 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2024-02-15

No results posted yet for this study

Summary

A growing body of work suggests that regular exercise can support symptom management and improve physical function for people living with multiple sclerosis (MS). Although exercise is known to be beneficial for managing many symptoms related to MS, its effects on the central nervous system, and whether these effects change with different types of exercise, are not well understood. Here, the investigators have designed a clinical trial that compares the effects of distinct exercise protocols on aspects of physical function, physical fitness, and central nervous system function. This research will be the first to compare the effects of different types of exercise on central nervous system changes in people with MS.

Conditions

  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Relapsing-Remitting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis

Interventions

OTHER

Exercise Group 1

Prescribed exercises will focus on mobility and balance.

OTHER

Exercise Group 2

Prescribed exercises will focus on physical fitness.

OTHER

Exercise Group 3

Prescribed exercises will focus on flexibility, range of motion, and muscle tone.

Sponsors & Collaborators

  • First Steps Wellness Centre

    collaborator UNKNOWN

  • Saskatchewan Health Research Foundation

    collaborator OTHER

  • University of Saskatchewan

    collaborator OTHER

  • University of Regina

    lead OTHER

Principal Investigators

  • Cameron Mang, PhD · University of Regina

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2024-10-31
Completion
2025-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05496881 on ClinicalTrials.gov